Oncology and Cellular Biology --;1. Recent Developments in the Treatment of Bladder Cancer --;2. Interferon-? Response and Signal Transduction Pathway in Transitional Carcinoma Cell Lines --;3. Molecular Cloning and Expression of Uroplakins in Transitional Cell Carcinoma --;4. Application of a Novel Protein Chip Mass Spectrometry Technology for the Identification of Bladder Cancer-Associated Biomarkers --;5. The Photodynamic Diagnosis (PDD) for Early Detection of Carcinoma and Dysplasia of the Bladder --;6. Prediction of Lymph Node Metastasis Based on P53 and nm23-Hl Expression in Muscle Invasive Grade III Transitional Cell Carcinoma of Bladder --;7. Detection of HER-2/neuCEP 17 Mutations at Invasive Bladder Cancer --;8. Ki67, P53, nm23, and DNA Cytometry in Bladder Cancer: Potential Markers for Detection of Recurrence --;9. Comparison of Cytology and Nuclear Matrix Protein 22 (NMP 22) for the Detection and Follow-Up of Bladder Cancer --;10. The Effect of Contrast Material on Transitional Cell Carcinoma Viability --;11. Fluorodeoxyglucose Positron Emission Tomography Studies in the Diagnosis and Staging of Transitional Cell Carcinoma --;12. Radiochemotherapy in Locally Invasive Non-Metastatic Carcinoma of the Bladder --;13. Gene and Antisense Therapy of Bladder Cancer --;14. Tumor Suppressor Genes of Bladder Cancer and Potential for Gene Therapy --;Muscle, Matrix, and Obstruction --;15. Molecular Response of the Bladder to Obstruction --;16. The Role of Lipids and Lipid Metabolites in Urinary Bladder Dysfunction Induced by Partial Outlet Obstruction --;17. Intercellular Communication and Bladder Function --;18. Ischemia as an Etiological Factor in Bladder Instability: Implications for Therapy --;19. Effect of Chronic Ischemia on Bladder Structure and Function --;20. Ultrastructural Diagnosis of Neuropathic Detrusor Overactivity: Validation of a Common Myogenic Mechanism --;21. Serial Changes of Smooth Muscle Cell Phenotypes in Rat Urinary Bladder Following Partial Outflow Obstruction --;22. Study of Detrusor Dysfunction Due to Outlet Obstruction: Link Between Analysis of Uroflows of Men with Benign Prostatic Hyperplasia and Animal Studies --;23. Ultrasonic Measurement of Bladder Weight as a Novel Urodynamic Modality --;Neurophysiology, Neurogenic Bladder, and Incontinence --;24. Experimental Neurogenic Cystitis --;25. Murine In Vitro Whole Bladder Physiology --;26. Ca2+ Sparks and KCa Channels: Novel Mechanisms to Relax Urinary Bladder Smooth Muscle --;27. The Effect of Intravesical Capsaicin and Resiniferatoxin in Neurogenic Bladder Dysfunction --;28. On the Physioanatomy of Micturition and Urinary Continence-New Concepts --;29. Stress Urinary Incontinence: New Concept of Pathogenesis and Treatment by Pudendal Canal Decompression --;30. Transcutaneous Electrovesicogram in Normal Volunteers and Patients with Interstitial Cystitis, Neurogenic Bladder, Benign Prostatic Hyperplasia, and after Cystectomy --;31. Extracorporeal Electromagnetic Stimulation for Urinary Incontinence and Bladder Disease --;32. Pubovaginal Sling Surgery without Using Abdominal Leak Point Pressure: An Outcomes Analysis --;33. The Use of Synthetic Materials in Pubovaginal Sling --;34. Surgical Implantation of the Synthetic Sling (The 6-Point Fixation Technique and Weight-Adjusted Spacing Nomogram): Technique and Results --;35. Reconstructive Surgery in Neuropathic Bladder --;36. The Role of the Simple Cystectomy in Urologic Surgery --;Immunology, Inflammation, and Infection --;37. Neurogenic Inflammation of the Bladder --;38. Urine-Induced Apoptosis in Cultured Bladder Urothelial Cells --;39. Bacillus of Calmette and Guerin Modulates Nuclear Factor Kappa? in Two Urothelial Carcinoma Cell Lines --;40. Induction of Urothelial Cell Proliferation by Fibroblast Growth Factor-7 in RAG 1-Deficient Mice --;41. Development of a Recombinant FimCH Vaccine for Urinary Tract Infections --;42. Intravesicular Pain Mapping --;43. A Hypothesis for the Etiology of Interstitial Cystitis --;44. Pentosanpolysulfate (Elmiron) is a Potent Inhibitor of Mast Cell Histamine Secretion --;45. The Efficacy of Intravesicular Sterile Sodium Chondroitin Sulfate 0.2% in Potassium Tested Positive Patients with Interstitial Cystitis --;46. Cystectomy Causes Immunosuppression in Bladder Cancer --;New Frontiers and Therapies --;47. Nocturia --;48. The Fate of Urinary Bladder Smooth Muscle after Outlet Obstruction --;A Role for the Sarcoplasmic Reticulum --;49. Alteration of Collagen Three-Dimensional Architecture in Noncompliant Human Urinary Bladder --;50. Modulation of Angiogenesis: Experimental Strategies and Potential Therapeutic Applications --;51. Methods of Testing Urethral Resistance in the Female Rat --;52. Virtual Reality Surgical Simulation for Lower Urinary Tract Endourologic Surgery --;53. Autologous Muscle Transfer for Reconstruction of the Lower Urinary Tract --;54. Effectiveness of Denuding the Intestinal Mucosa by Submucosal Injection in the Porcine Model --;55. Urinary Diversion in the Management of Chronic Perineal Skin Ulceration in Spinal Cord Injured Patients Following Sphincterotomy --;56. The Artificial Urinary Bladder --;57. Comparison of the Breaking Strength of Polyglactin Mesh in Urine, Serum, and Cell Culture Media --;58. Growth of Cultured Human Urothelial Cells Into Stratified Urothelial Sheet Suitable for Autografts --;59. Future Perspectives in Bladder Reconstruction.
In 1996, the National Bladder Foundation (NBF) was founded by a dedicated group of physicians and researchers propeIled by the urgent need to find better treatments for bladder disease.